Prostate Disease: Clinical Trials

3 trials for Prostate Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow Prostate Disease: new trials by email Literature Review of Prostate Disease trials Research Report on Prostate Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
Nivolumab, Brachytherapy, External Beam Radiation Therapy - Prostate Cancer, Prostate Disease
Phase 1 / Phase 2CompletedH. Lee Moffitt Cancer Center and Research Institute442018-10-032026-09-16
In Vivo Dosimetry During Prostate Cancer Radiotherapy
Plastic Scintillation Detectors - Prostate Disease
Phase 1CompletedM.D. Anderson Cancer Center72011-11-012016-04-06
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
dehydrated alcohol - Prostate Disease, BPH
Phase 1 / Phase 2CompletedAmerican Medical Systems1502002-03-012007-10-10

Narrower conditions

Prostatic Diseases (3)  ·  Prostatic Hyperplasia (1)  ·  Prostatic Neoplasms (1)  ·  Prostatitis (1)

Broader conditions

Genital Diseases (3)  ·  Genital Diseases, Male (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Genital Neoplasms, Male (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Urogenital Neoplasms (1)

Interventions

Androgen Antagonists (1)  ·  Brachytherapy (1)  ·  Ethanol (1)  ·  Nivolumab (1)  ·  Radiotherapy (1)

Sponsors

American Medical Systems (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (2)

Top investigators

Kosj Yamoah, M.D., Ph.D. (1)  ·  Sam Beddar, PHD (1)

Results publications

PMID 32651467

NIH funding

R01CA120198 (1)